FDA approves blood disorder drug made by Japan's Shionogi
The U.S. Food and Drug Administration on Tuesday approved Japan-based Shionogi& Co Ltd's treatment for low blood-platelet count or thrombocytopenia in patients with chronic liver disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Food and Drug Administration (FDA) | Health | Japan Health | Liver | Liver Disease | Thrombocytopenia | Urology & Nephrology